$LABTJun 23, 2026, 4:16 PMAI processedSCHEDULE 13G
HPW Investments reports 24.04% stake in Lakewood-Amedex (Schedule 13G)
AI Summary
ISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. filed SEC Form SCHEDULE 13G. HPW Investments Holding Ltd. reported beneficial ownership of 3,435,501 common shares of Lakewood-Amedex Biotherapeutics (LABT), equal to 24.04% of 14,290,892 shares outstanding as of March 31, 2026, in a Schedule 13G filed 06/23/2026. The filer states it has sole voting and sole dispositive power over all 3,435,501 shares and lists its principal business office in Jersey.
Positives
- HPW Investments beneficially owns 3,435,501 shares, representing 24.04% of outstanding common shares (14,290,892 basis).
- Filer reports sole voting power and sole dispositive power over the entire reported position.
- Position disclosed via Schedule 13G filed 06/23/2026 (public ownership disclosure).
Negatives
No negative notes were stored with this alert.